TeraRecon, Inc.
TeraRecon President and CEO, Jeff Sorenson, explains how the FDA has continued to show their dedication to fostering the development of AI in healthcare.
Source
Episode 7 | AI Conversation Series | Where is the FDA on Artificial Intelligence?
